Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Equal-Weight on Summit Materials, Raises Price Target to $36

Morgan Stanley analyst Courtney Yakavonis maintains Summit Materials (NYSE:SUM) with a Equal-Weight and raises the price target from $35 to $36.
byBenzinga Newsdesk
October 13, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley analyst Courtney Yakavonis maintains Summit Materials (NYSE:SUM) with a Equal-Weight and raises the price target from $35 to $36.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

FDA Approves Merck’s KEYTRUDA For Patients With MSI‑H/dMMR Advanced Endometrial Carcinoma, Who Have Disease Progression Following Prior Systemic Therapy in Any Setting And Are Not Candidates For Curative Surgery Or Radiation

By Bill Haddad
Today, 4:36 AM
  Based on KEYNOTE-158 Trial, Patients Receiving KEYTRUDA Demonstrated an Objective Response Rate of 46% Approval Marks Fourth Gynecologic Cancer Indication for KEYTRUDA KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck

MRK